These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10206431)

  • 1. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency.
    Julve-Gil J; Ruiz-Pérez E; Casaroli-Marano RP; Marzal-Casacuberta A; Escolà-Gil JC; González-Sastre F; Blanco-Vaca F
    Metabolism; 1999 Apr; 48(4):415-21. PubMed ID: 10206431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
    Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
    J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.
    Flores R; Jin X; Chang J; Zhang C; Cogan DG; Schaefer EJ; Kruth HS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.
    Escolà-Gil JC; Marzal-Casacuberta A; Julve-Gil J; Ishida BY; Ordóñez-Llanos J; Chan L; González-Sastre F; Blanco-Vaca F
    J Lipid Res; 1998 Feb; 39(2):457-62. PubMed ID: 9580110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel in vivo lecithin-cholesterol acyltransferase (LCAT)-deficient mouse expressing predominantly LpX is associated with spontaneous glomerulopathy.
    Zhu X; Herzenberg AM; Eskandarian M; Maguire GF; Scholey JW; Connelly PW; Ng DS
    Am J Pathol; 2004 Oct; 165(4):1269-78. PubMed ID: 15466392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
    Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
    J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lecithin/cholesterol acyltransferase modulates diet-induced hepatic deposition of triglycerides in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Triantafyllidou IE; Kypreos KE
    J Nutr Biochem; 2013 Mar; 24(3):567-77. PubMed ID: 22819565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial lecithin:cholesterol acyltransferase deficiency. Biochemistry of the cornea.
    Winder AF; Garner A; Sheraidah GA; Barry P
    J Lipid Res; 1985 Mar; 26(3):283-7. PubMed ID: 3989388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
    Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
    Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.
    Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human apolipoproteins A-I and A-II in cell cholesterol efflux: studies with transgenic mice.
    Chiesa G; Parolini C; Canavesi M; Colombo N; Sirtori CR; Fumagalli R; Franceschini G; Bernini F
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1417-23. PubMed ID: 9743230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human LCAT normalizes plasma lipoprotein profile in LCAT deficiency.
    Simonelli S; Tinti C; Salvini L; Tinti L; Ossoli A; Vitali C; Sousa V; Orsini G; Nolli ML; Franceschini G; Calabresi L
    Biologicals; 2013 Nov; 41(6):446-9. PubMed ID: 24140107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lecithin:Cholesterol Acyltransferase (LCAT) Deficiency Promotes Differentiation of Satellite Cells to Brown Adipocytes in a Cholesterol-dependent Manner.
    Nesan D; Tavallaee G; Koh D; Bashiri A; Abdin R; Ng DS
    J Biol Chem; 2015 Dec; 290(51):30514-29. PubMed ID: 26494623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A normal rate of cellular cholesterol removal can be mediated by plasma from a patient with familial lecithin-cholesterol acyltransferase (LCAT) deficiency.
    Bérard AM; Clerc M; Brewer B; Santamarina-Fojo S
    Clin Chim Acta; 2001 Dec; 314(1-2):131-9. PubMed ID: 11718688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perturbations in the HDL metabolic pathway predispose to the development of osteoarthritis in mice following long-term exposure to western-type diet.
    Triantaphyllidou IE; Kalyvioti E; Karavia E; Lilis I; Kypreos KE; Papachristou DJ
    Osteoarthritis Cartilage; 2013 Feb; 21(2):322-30. PubMed ID: 23151457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transport.
    Castro G; Nihoul LP; Dengremont C; de Geitère C; Delfly B; Tailleux A; Fievet C; Duverger N; Denèfle P; Fruchart JC; Rubin EM
    Biochemistry; 1997 Feb; 36(8):2243-9. PubMed ID: 9047326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo imaging of the cornea in a patient with lecithin-cholesterol acyltransferase deficiency.
    Palmiero PM; Sbeity Z; Liebmann J; Ritch R
    Cornea; 2009 Oct; 28(9):1061-4. PubMed ID: 19724202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
    Furbee JW; Parks JS
    Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compound heterozygosity (G71R/R140H) in the lecithin:cholesterol acyltransferase (LCAT) gene results in an intermediate phenotype between LCAT-deficiency and fish-eye disease.
    Hörl G; Kroisel PM; Wagner E; Tiran B; Petek E; Steyrer E
    Atherosclerosis; 2006 Jul; 187(1):101-9. PubMed ID: 16216249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.